- Home
- GHM vs OPK Comparison
GHM vs OPK Comparison
Compare GHM & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GHM | OPK |
|---|---|---|
| Founded | 1936 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 899.3M | 921.2M |
| IPO Year | 1994 | 2011 |
Fundamental Metrics
Financial Performance| Metric | GHM | OPK |
|---|---|---|
| Price | $95.17 | $1.23 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $73.33 | $1.60 |
| AVG Volume (30 Days) | 148.5K | ★ 2.2M |
| Earning Date | 06-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 164.29 | N/A |
| EPS | ★ 0.95 | N/A |
| Revenue | $209,896,000.00 | ★ $606,879,000.00 |
| Revenue This Year | $14.54 | N/A |
| Revenue Next Year | $18.23 | $4.24 |
| P/E Ratio | $97.86 | ★ N/A |
| Revenue Growth | ★ 13.13 | N/A |
| 52 Week Low | $35.85 | $0.98 |
| 52 Week High | $103.53 | $1.60 |
Technical Indicators
Market Signals| Indicator | GHM | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 51.39 | 65.67 |
| Support Level | $87.90 | $1.12 |
| Resistance Level | $98.40 | $1.27 |
| Average True Range (ATR) | 4.93 | 0.04 |
| MACD | -0.77 | 0.01 |
| Stochastic Oscillator | 37.91 | 96.88 |
Price Performance
Historical ComparisonAbout GHM Graham Corporation
Graham Corporation designs and manufactures mission-critical fluid, power, heat transfer, and vacuum technologies for the defense, space, energy, and process industries. The company also services and sells spare parts for its equipment. It designs and manufactures custom-engineered vacuum, heat transfer, cryogenic pump and turbomachinery technologies.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.